本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Processa Pharmaceuticals, Inc.

2.59
-0.0100-0.38%
盤後2.52-0.0700-2.70%19:34 EDT
成交量:6.14萬
成交額:16.31萬
市值:716.91萬
市盈率:-0.24
高:2.74
開:2.69
低:2.53
收:2.60
52周最高:14.24
52周最低:1.67
股本:276.80萬
流通股本:266.84萬
量比:0.63
換手率:2.30%
股息:- -
股息率:- -
每股收益(TTM):-10.9007
每股收益(LYR):-96.8176
淨資產收益率:-464.99%
總資產收益率:-193.89%
市淨率:2.82
市盈率(LYR):-0.03

資料載入中...

公司資料

公司名字:
Processa Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2015
員工人數:
12
公司地址:
601 21st Street,Suite 300,Vero Beach,Florida,United States
郵編:
32960
電話:
傳真:
443 288 4420
簡介:
Processa Pharmaceuticals, Inc.成立於2011年3月29日。該公司是一家臨床階段的生物製藥公司,正在開發下一代癌症治療小分子管線,其中兩個正在進行或已完成2期試驗,一個正在進行臨床前開發。

董事

名稱
職位
George Ng
Chief Executive Officer and Director
Justin Yorke
Chairman of the Board and Director
David Young
Director and President of Research and Development
Geraldine Pannu
Director
James Neal
Director
Khoso Baluch
Director

股東

名稱
職位
George Ng
Chief Executive Officer and Director
Russell Skibsted
Chief Financial Officer
David Young
Director and President of Research and Development
Patrick Lin
Chief Business and Strategy Officer
Wendy Guy
Chief Administrative Officer